Mostrar el registro sencillo del ítem
| dc.contributor.author | García-Bernal, David | |
| dc.contributor.author | Richardson, Edward | |
| dc.contributor.author | Vlodavsky, Israel | |
| dc.contributor.author | Carlo-Stella, Carmelo | |
| dc.contributor.author | Iacobelli, Massimo | |
| dc.contributor.author | Jara, Rubén | |
| dc.contributor.author | Richardson, Paul-G | |
| dc.contributor.author | Moraleda-Jiménez, José-María | |
| dc.date.accessioned | 2025-11-18T09:26:32Z | |
| dc.date.available | 2025-11-18T09:26:32Z | |
| dc.date.issued | 2021-08 | |
| dc.identifier.citation | García-Bernal D, Richardson E, Vlodavsky I, Carlo-Stella C, Iacobelli M, Jara R, et al. Endothelial dysfunction and its critical role in COVID-19-associated coagulopathy: Defibrotide as an endothelium-protective, targeted therapy. eJHaem. agosto de 2021;2(3):680-1. | |
| dc.identifier.issn | 2688-6146 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/20719 | |
| dc.description.abstract | INTRODUCTION: The increase in the number of patients with hemoglobinopathies in Europe in recent decades highlights the need for more detailed epidemiological information in Spain. To fulfil this need, the Spanish Society of Pediatric Hematology and Oncol | |
| dc.language.iso | eng | |
| dc.publisher | Wiley | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | beta-Thalassemia/complications/epidemiology/therapy | |
| dc.subject.mesh | Blood Transfusion | |
| dc.subject.mesh | Demography | |
| dc.subject.mesh | Hemosiderosis | |
| dc.subject.mesh | Iron Overload/etiology | |
| dc.title | Endothelial dysfunction and its critical role in COVID-19-associated coagulopathy: Defibrotide as an endothelium-protective, targeted therapy | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 34518829 | |
| dc.relation.publisherversion | https://onlinelibrary.wiley.com/doi/10.1002/jha2.198 | |
| dc.identifier.doi | 10.1002/jha2.198 | |
| dc.journal.title | Ejhaem |